In Vivo, Evaluation of Wound Healing Activity of Nanoliposomes Loaded Withania somnifera Extract.

IF 4.1 Q2 PHARMACOLOGY & PHARMACY Advanced pharmaceutical bulletin Pub Date : 2024-12-30 Epub Date: 2024-12-05 DOI:10.34172/apb.42403
Mohadese Mirshekari, Azar Bagheri Ghomi, Hamed Hamishehkar, Mohammad Reza Farahpour
{"title":"<i>In Vivo</i>, Evaluation of Wound Healing Activity of Nanoliposomes Loaded <i>Withania somnifera</i> Extract.","authors":"Mohadese Mirshekari, Azar Bagheri Ghomi, Hamed Hamishehkar, Mohammad Reza Farahpour","doi":"10.34172/apb.42403","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Medicinal plants and their derivatives have been used to treat wounds, and loading the plants into nanoliposomes (NLPs) helps to increase their efficacy. This study investigated the efficacy of NLPs loaded with <i>Withania somnifera</i> (WHSE) extract in mouse models for excisional wound healing.</p><p><strong>Methods: </strong>In the present study, we thoroughly evaluated WHSE's antibacterial, antioxidant, and safety profiles. Additionally, we assessed wound contraction, pathological evaluations, and the expression of basic fibroblast growth factor (bFGF) and CD31.</p><p><strong>Results: </strong>The results showed that the extract and its NLPs had biocompatibility and exhibited antibacterial and antioxidant properties. Furthermore, our in vivo wound healing assay results showed that ointments containing 0.50% and 1.00% of the WHSE-NLPs accelerated wound healing and increased collagen and epithelialization. Furthermore, the results of the immunofluorescence and immunochemical tests indicated more expression of CD31 and bFGF in the mice that have been treated with WHSE-NLPs compared to those who were treated with WHSE and control groups. (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>We demonstrated that the administration of 1.00% of the WHSE-NLPs could compete with the commercial ointment (Nitrofurazone®). Therefore, balms prepared from WHSE-NLPs expedited the wound healing process by increasing collagen, epithelialization, and the expression of CD31 and bFGF.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"14 4","pages":"846-857"},"PeriodicalIF":4.1000,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970498/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced pharmaceutical bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/apb.42403","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Medicinal plants and their derivatives have been used to treat wounds, and loading the plants into nanoliposomes (NLPs) helps to increase their efficacy. This study investigated the efficacy of NLPs loaded with Withania somnifera (WHSE) extract in mouse models for excisional wound healing.

Methods: In the present study, we thoroughly evaluated WHSE's antibacterial, antioxidant, and safety profiles. Additionally, we assessed wound contraction, pathological evaluations, and the expression of basic fibroblast growth factor (bFGF) and CD31.

Results: The results showed that the extract and its NLPs had biocompatibility and exhibited antibacterial and antioxidant properties. Furthermore, our in vivo wound healing assay results showed that ointments containing 0.50% and 1.00% of the WHSE-NLPs accelerated wound healing and increased collagen and epithelialization. Furthermore, the results of the immunofluorescence and immunochemical tests indicated more expression of CD31 and bFGF in the mice that have been treated with WHSE-NLPs compared to those who were treated with WHSE and control groups. (P<0.05).

Conclusion: We demonstrated that the administration of 1.00% of the WHSE-NLPs could compete with the commercial ointment (Nitrofurazone®). Therefore, balms prepared from WHSE-NLPs expedited the wound healing process by increasing collagen, epithelialization, and the expression of CD31 and bFGF.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
纳米脂质体在体内伤口愈合活性的研究。
目的:药用植物及其衍生物已被用于治疗伤口,而将植物载入纳米脂质体(NLPs)有助于提高其疗效。本研究调查了载入了睡莲(WHSE)提取物的纳米脂质体在小鼠切除伤口愈合模型中的疗效:在本研究中,我们全面评估了 WHSE 的抗菌、抗氧化和安全性。此外,我们还评估了伤口收缩、病理评估以及碱性成纤维细胞生长因子(bFGF)和 CD31 的表达:结果:研究结果表明,萃取物及其 NLPs 具有生物相容性、抗菌性和抗氧化性。此外,我们的体内伤口愈合试验结果表明,含有 0.50% 和 1.00% WHSE-NLPs 的软膏可加速伤口愈合,增加胶原蛋白和上皮化。此外,免疫荧光和免疫化学测试结果表明,与使用 WHSE 和对照组相比,使用 WHSE-NLPs 的小鼠体内 CD31 和 bFGF 的表达量更高。(结论:我们证明,使用1.00%的WHSE-NLPs可与商用软膏(Nitrofurazone®)相抗衡。因此,由 WHSE-NLPs 制备的药膏可通过增加胶原蛋白、上皮化以及 CD31 和 bFGF 的表达来加速伤口愈合过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advanced pharmaceutical bulletin
Advanced pharmaceutical bulletin PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
2.80%
发文量
51
审稿时长
12 weeks
期刊最新文献
The Pharmaceutical Industry's Future: How Artificial Intelligence is Transforming Medicine. Genosomes: An Introspection into Transfection, Future Perspectives and Applications. Localized Semaglutide Injection for Hyperinsulinemia-Induced Lymphatic Dysfunction: A Narrative Review Proposing a Promising Metabolic Perspective for Lymphedema Therapy. An Insight Into the Aerosolization Pattern of Formoterol Fumarate Dry Powder Inhalation Formulation Actuated Via Two Different Inhaler Devices. Metformin as a Metabolic Adjuvant to Amoxicillin: A Hypothesis on Synergistic Antibacterial Action.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1